Espaçolaser (B3: ESPA3) revenue
Espaçolaser reported revenue of BRL 1,093m for fiscal 2025, 6.1% more than in fiscal 2024 (BRL 1,030m). Since fiscal 2019 its revenue has grown by 68.8%, an average growth of 9.1% a year.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | BRL 1,093m | +6.1% | BRL 171.7m | 15.7% |
| 2024 | BRL 1,030m | +2.3% | BRL 150.0m | 14.6% |
| 2023 | BRL 1,006m | +11.0% | BRL 127.7m | 12.7% |
| 2022 | BRL 906.5m | +26.9% | BRL 104.0m | 11.5% |
| 2021 | BRL 714.3m | +36.9% | BRL 228.5m | 32.0% |
| 2020 | BRL 521.9m | −19.4% | BRL 68.7m | 13.2% |
| 2019 | BRL 647.6m | — | BRL 158.6m | 24.5% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of Brazilian reais, except per-share amounts.
Questions about the revenue of Espaçolaser
- How much revenue did Espaçolaser make in fiscal 2025?
- Espaçolaser reported revenue of BRL 1,093m for fiscal 2025, compared with BRL 1,030m in fiscal 2024.
- How much has the revenue of Espaçolaser grown?
- Between fiscal 2019 and fiscal 2025 it went from BRL 647.6m to BRL 1,093m: 68.8% more, an average growth of 9.1% a year.
- What was the best year for revenue at Espaçolaser?
- Of its last 7 fiscal years, fiscal 2025, with BRL 1,093m.
- Where do the figures for Espaçolaser come from?
- From the annual financial statements (DFP) that Espaçolaser files with the CVM, the Brazilian securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual financial statements (DFP) that Espaçolaser files with the CVM, the Brazilian securities regulator. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019. More on Espaçolaser: the Espaçolaser page · annual accounts · net income · dividends paid.
More companies from Brazil and the rest of the region: Latin American stocks.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.